Invention Grant
US08986712B2 Peptides derived from HIV-1 gp41 transmembrane domain for t-immunomodulation
有权
衍生自HIV-1 gp41跨膜结构域的肽用于t-免疫调节
- Patent Title: Peptides derived from HIV-1 gp41 transmembrane domain for t-immunomodulation
- Patent Title (中): 衍生自HIV-1 gp41跨膜结构域的肽用于t-免疫调节
-
Application No.: US13512556Application Date: 2010-11-29
-
Publication No.: US08986712B2Publication Date: 2015-03-24
- Inventor: Yechiel Shai , Irun R. Cohen , Tomer Cohen
- Applicant: Yechiel Shai , Irun R. Cohen , Tomer Cohen
- Applicant Address: IL Rehovot
- Assignee: Yeda Research and Development Co., Ltd.
- Current Assignee: Yeda Research and Development Co., Ltd.
- Current Assignee Address: IL Rehovot
- Agency: Booth Udall Fuller, PLC
- Agent Rodney J. Fuller
- International Application: PCT/IL2010/000995 WO 20101129
- International Announcement: WO2011/064779 WO 20110603
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K38/08 ; A61K38/04 ; A61K38/10 ; A61K38/16 ; C07K14/005 ; A61P11/00 ; A61P37/02 ; A61P37/08
Abstract:
The present invention relates to peptides, derivatives and analogs comprising an amino acid sequence derived from the transmembrane domain of HIV gp41 protein, pharmaceutical compositions comprising same, and uses thereof for therapy of inflammatory diseases and disorders, such as T-cell and/or monocyte mediated diseases.
Public/Granted literature
- US20120321668A1 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE Public/Granted day:2012-12-20
Information query
